Look Kirk
Chief Financial Officer
Look Kirk has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 13, 2026.
On the most recent filing, Look Kirk is listed as Chief Financial Officer at ONCOLYTICS BIOTECH INC. Inside the rolling window, Look Kirk reported 1 open-market purchase totaling $10K in ONCY and no open-market sales.
Companies traded
Other insiders at ONCY
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Look Kirk made?
Look Kirk has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Look Kirk trade?
Look Kirk has filed SEC Form 4 disclosures for 1 company, including ONCY.
When was Look Kirk's most recent SEC Form 4 filing?
Look Kirk's most recent SEC Form 4 filing on Tracefour is dated Feb 13, 2026.
What is Look Kirk's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Look Kirk is listed as Chief Financial Officer.
What is Look Kirk's total buy and sell value in the current window?
Inside the rolling retention window, Look Kirk bought $10K and sold $0 based on SEC Form 4 filings.
What was Look Kirk's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 12,000 ONCY shares on 2026-02-12, worth $10K, per SEC Form 4 filings.